Jim Tananbaum’s Success in the Health Service Industry

Foresite capital is an American growth and equity firm with offices in San Francisco and New York. Jim Tananbaum, who is the current CEO, founded the company in 2011. The company provides funds to start up health providers to help them become stronger.

Recently the company included a new partner to their team, Dr. Molly He. Dr. He formerly worked as a senior director at Illumina. Dr. He is expected to bring a lot to the table with over 15 years of experience in both pharmaceutical and genomic research and development.

Foresite Capital was thrilled to have her join their team as she is among the most respected scientific researchers in the field of next generation sequencing. While working at Illumina Dr. He was able to come up with the company’s protein reagent innovation and improvements that gained global recognition.

Earlier in her career, Dr. He had spent some time trying to work out an antibody that was to be responsible for aiding cancer patients and immune diseases. Dr. He holds a Bachelor’s degree in biochemistry from Nankai University and a Ph.D. in protein biophysics from the University of California, Los Angeles. Forsite Capital believe that she will be able to further their cause and she will help the company to move forward.

Jim Tananbaum graduated from Yale with B.S and B.S.E.E. He then decided to further his studies and graduated with an M.D from Harvard Medical School. He also holds an M.B.A from Harvard Business School.

Dr. Tananbaum decided to focus on strategic, operational, and financial opportunities that are aimed at building developing franchise healthcare businesses. He has been in the industry of medical entrepreneurship for over 25 years. During this period, Jim Tananbaum has been involved in the founding of many healthcare franchises. He was the Co-founder of GelTex Pharmaceuticals that was responsible for developing two new drugs before it was bought for $1.6 million, reveals Bloomberg. He also co-founded Theravance, Inc. and Prospect Venture Partners.

Jim was recently added to Forbes Midas List for the top tech investors. He was placed on this list due to his investments in the new upcoming trends in the medical business and his contributions to the industry.

Source: https://www.linkedin.com/in/jim-tananbaum-a7562a7/

Comments are disabled